First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

With a new generation of fast and affordable gene sequencers, researchers are better equipped than ever to tackle Earth’s ...

JABSOM Cell and Molecular Biology researcher Dr. Jesse Owens has spent the better part of two decades chasing a vision that ...

A groundbreaking gene-editing method from UT Austin is changing the game for treating complex genetic diseases like cystic fibrosis, hemophilia, and Tay Sachs. Using retrons—DNA tools borrowed from ...

Tuberculosis (TB) is one of the oldest and deadliest infectious diseases we know. It commonly impacts the lungs, but can also affect other areas of the body like the spine, brain or kidneys.

Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.

Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, today announces the appointment of Francis Van Parys as Chief Executive ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

The OSHWC Code, 2020 and Social Security Code enhance worker protection in pharma through risk management, medical surveillance, and competency-based ...

FDA grants a Type A meeting on December 18th to review new and expanded datasets submitted by Saol to help identify a feasible path forward without the need for an additional clinical trial ROSWELL, ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...